Ultrasonic head structure and ultrasonic equipment

By setting the first and second storage chambers in the ultrasonic head structure and circulating with cooling fluid, the problems of low heat dissipation and drug penetration efficiency of ultrasonic head are solved, and better skin fit and drug penetration effects are achieved.

CN118950441AInactive Publication Date: 2024-11-15SHENZHEN XIZI RUICHENG TECHNOLOGY PARTNERSHIP (LLP)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411039755.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing ultrasound heads are difficult to dissipate heat during ultrasound treatment, resulting in heat accumulation, low drug penetration efficiency, and electrode patches and ultrasound coupled patches are prone to be unsolidly bonded, resulting in reduced ultrasound transmission efficiency.

Method used

An ultrasonic head structure is designed, including a first receiving cavity for receiving coupling fluid and a second receiving cavity for receiving cooling fluid. The piezoelectric element is located in the first receiving cavity. The acoustic radiation surface faces toward the ultrasonic port and the cooling fluid passes through the outlet. and inlet flow, reducing heat accumulation, and communicating with the cooling tank through the liquid leakage hole, ensuring that the flow of the cooling fluid does not affect the pressure of the coupled fluid.

Benefits of technology

It improves the adsorption force between the ultrasonic head and the skin, enhances the penetration efficiency of drug, achieves effective heat dissipation, reduces heat accumulation and drug diffusion resistance, and improves the uniform distribution of ultrasonic energy and the penetration effect of drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118950441A_ABST
    Figure CN118950441A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of ultrasound, in particular to an ultrasonic head structure and ultrasonic equipment. The ultrasonic head structure includes an ultrasonic head body and at least one piezoelectric element. The ultrasonic head body is provided with a first containing cavity and a second containing cavity in a spaced mode, the ultrasonic head body is further provided with an ultrasonic opening communicated with the first containing cavity, an outlet and an inlet, the outlet and the inlet are communicated with the second containing cavity, the first containing cavity is used for containing coupling fluid, and the second containing cavity is used for containing cooling fluid. The piezoelectric element is connected to the ultrasonic head body and located in the first containing cavity, the piezoelectric element and the ultrasonic opening are arranged in a spaced mode, and the sound radiation surface of the piezoelectric element faces the ultrasonic opening. By arranging the first containing cavity and the second containing cavity, the adsorption force of the ultrasonic head structure and the skin can be improved, the medicine permeation efficiency can be improved, and meanwhile heat dissipation can be facilitated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of ultrasonic technology, and in particular to an ultrasonic head structure and an ultrasonic device. Background Art

[0002] Transdermal drug delivery is an alternative to traditional intravenous and oral drug delivery, and ultrasound-assisted drug penetration is also one of the important methods of transdermal drug delivery. The current treatment head generally adheres a half-wavelength aluminum lens under the condition of thickness resonance frequency to the emitting surface of the piezoelectric array element. If radial vibration is performed, its vibration damping is greatly increased. Under long-term working conditions, heat accumulation is likely to occur, causing skin discomfort to the user.

[0003] In addition, the current treatment head needs to be combined with an electrode patch and an ultrasonic coupling patch (a medium for transmitting ultrasound to the skin) when performing ultrasonic conductivity work. The electrode patch and the ultrasonic coupling patch are prone to loose adhesion and the formation of an air layer, which reduces the efficiency of ultrasound transmission to the skin. Summary of the invention

[0004] Based on this, it is necessary to provide an ultrasonic head structure and an ultrasonic device to address the problems of the current ultrasonic head being difficult to dissipate heat and having low drug penetration efficiency.

[0005] In a first aspect, an ultrasonic head structure includes:

[0006] An ultrasonic head body, wherein a first accommodating cavity and a second accommodating cavity are provided in the ultrasonic head body, and the ultrasonic head body is further provided with an ultrasonic port communicated with the first accommodating cavity and an outlet and an inlet communicated with the second accommodating cavity, the first accommodating cavity is used to accommodate a coupling fluid, and the second accommodating cavity is used to accommodate a cooling fluid; and

[0007] At least one piezoelectric element is connected to the ultrasonic head body and is located in the first accommodating cavity. The piezoelectric element is spaced apart from the ultrasonic port, and the sound radiation surface of the piezoelectric element faces the ultrasonic port.

[0008] In one embodiment, the ultrasonic head body includes a first part and a second part stacked along a first direction, the first part is provided with the first accommodating cavity and the ultrasonic port along the first direction and on a surface facing away from the second part, the piezoelectric element is connected to the first part, the second part is provided with the second accommodating cavity along the first direction and on a surface adjacent to the first part, the second accommodating cavity extends along the second direction to the peripheral side surface penetrating the second part to form the outlet and the inlet, and the first direction intersects with the second direction.

[0009] In one embodiment, a leakage hole is provided on a surface of the first portion along the first direction and adjacent to the second portion, and the leakage hole is communicated with the first accommodating cavity and the second accommodating cavity at the same time.

[0010] In one embodiment, the first part includes a base and a plurality of enclosures, and the piezoelectric elements include a plurality of piezoelectric elements. In the first direction, the surface of the base is connected to the second part, and all the enclosures are protruded from the surface of the base facing away from the second part. All the enclosures and the base are jointly configured to form the first accommodating cavity, and each of the enclosures is provided with an ultrasonic port, and each of the piezoelectric elements is located in one of the enclosures.

[0011] In one embodiment, the enclosure is a ring, the piezoelectric element is a cylinder, and each of the piezoelectric elements is concentrically arranged with each of the enclosures;

[0012] And / or, the diameter d1 of the piezoelectric element is 8 mm to 12 mm;

[0013] And / or, the thickness d2 of the piezoelectric element is 0.5 mm to 3 mm;

[0014] And / or, the center distance d3 between two adjacent piezoelectric elements is 15 mm to 25 mm;

[0015] And / or, the distance d4 between the outer circumference of the piezoelectric element and the inner circumference of the enclosure is 0.5 mm to 1.5 mm;

[0016] And / or, the distance d5 between the inner circumference and the outer circumference of the enclosure is 1.5 mm to 2.5 mm;

[0017] And / or, along the first direction and in a direction away from the substrate, a distance d6 between a bottom surface of the piezoelectric element and a bottom surface of the enclosure is 0.5 mm to 1.5 mm.

[0018] In one embodiment, each of the piezoelectric elements includes a piezoelectric array element, a positive electrode lead and a ground electrode lead, the positive electrode lead and the ground electrode lead are arranged coplanarly, the piezoelectric array element is connected to the bottom surface of the substrate, and the parts of the positive electrode lead and the ground electrode lead electrically connected to the piezoelectric array element are embedded in the substrate.

[0019] In one embodiment, the second accommodating cavity includes a plurality of cooling grooves and a plurality of cooling channels. In the second direction, the cooling channels are located around the cooling grooves, and two adjacent cooling grooves are connected by the cooling channels. The contour size of the cooling grooves is greater than or equal to the contour size of the piezoelectric element. In the first direction, the contour edge of the cooling groove coincides with the contour edge of the piezoelectric element or is located outside the contour edge of the piezoelectric element.

[0020] In one embodiment, a leakage hole is provided on a surface of the first portion along the first direction and adjacent to the second portion, and the leakage hole is communicated with the first accommodating cavity and the cooling groove respectively.

[0021] In one of the embodiments, the peripheral surface and bottom surface of the piezoelectric element facing the ultrasonic port are covered with a protective layer, and the material of the protective layer and the material of the ultrasonic head body are both flexible materials.

[0022] In a second aspect, an ultrasonic device comprises the ultrasonic head structure as described in the first aspect.

[0023] In the above-mentioned ultrasonic head structure, the first accommodating chamber is only used to accommodate the coupling fluid and set the piezoelectric element, which effectively reduces the contents in the first accommodating chamber, enables the ultrasonic head structure to better fit the human skin, can better adapt to the skin curve, provide better skin fit, and thus can increase the adsorption force between the ultrasonic head structure and the human skin. At the same time, the first accommodating chamber is only provided with the coupling fluid and the piezoelectric element, which can reduce the diffusion resistance of the drug inside the cavity, enable the ultrasonic energy to be evenly distributed, reduce the energy loss caused by skin displacement, and improve the drug penetration efficiency. After the first accommodating chamber of the ultrasonic head structure accommodates the coupling fluid, the ultrasonic port covers the human skin, so that the ultrasonic head structure is adsorbed on the human skin, and the coupling fluid is prevented from overflowing from the edge of the ultrasonic port. The piezoelectric element is arranged at intervals with the ultrasonic port, so that a distance is formed between the piezoelectric element and the skin surface, and the sound radiation surface of the piezoelectric element faces the ultrasonic port, so that the coupling fluid in the first accommodating chamber can induce the coupling fluid to produce inertial cavitation, convective mixing and micro-jet formation on the skin surface, which can facilitate breaking through the obstruction of the stratum corneum and improve the drug penetration efficiency. By introducing the cooling fluid from the inlet into the second accommodating chamber and then passing it out through the outlet, the cooling fluid flows in the second accommodating chamber. The cooling fluid has a larger heat capacity and can effectively take away the heat generated by the piezoelectric element when it is working to prevent overheating. Since the second accommodating chamber is spaced apart from the first accommodating chamber, the pressure change caused by the cooling fluid flowing in the second accommodating chamber will not directly affect the first accommodating chamber, and the pressure in the first accommodating chamber can be kept stable, the transmission of pressure waves can be reduced, and the risk of leakage of the coupling liquid in the first accommodating chamber can be reduced. Therefore, the embodiment of the present application can not only improve the adsorption force between the ultrasonic head structure and the skin, but also improve the drug penetration efficiency, and can also facilitate heat dissipation by setting the first accommodating chamber and the second accommodating chamber. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the conventional technology, the drawings required for use in the embodiments or the conventional technology descriptions are briefly introduced below. Obviously, the drawings described below are merely embodiments of the present application, and ordinary technicians in this field can obtain other drawings based on the disclosed drawings without paying any creative work.

[0025] FIG. 1 is a three-dimensional diagram of an ultrasonic head structure provided in an embodiment of the present application.

[0026] FIG. 2 is an exploded view of an ultrasonic head structure provided in an embodiment of the present application.

[0027] FIG. 3 is a bottom view of an ultrasonic head structure provided in an embodiment of the present application.

[0028] FIG. 4 is a side view of the structure of an ultrasonic head provided in an embodiment of the present application.

[0029] FIG. 5 is a three-dimensional diagram of a first portion of an ultrasonic head structure provided in an embodiment of the present application.

[0030] FIG. 6 is a three-dimensional diagram of a second part of an ultrasonic head structure provided in an embodiment of the present application.

[0031] FIG. 7 is a three-dimensional diagram of a piezoelectric element of an ultrasonic head structure provided in an embodiment of the present application.

[0032] FIG8 is a schematic diagram of an ultrasonic head structure provided in an embodiment of the present application in which a protective layer is provided on a piezoelectric array element.

[0033] Explanation of the reference numerals: 100, ultrasonic head structure; 1, ultrasonic head body; 11, first part; 111, first accommodating cavity; 112, ultrasonic port; 113, leakage hole; 114, base; 115, enclosure; 12, second part; 121, second accommodating cavity; 1211, cooling groove; 1212, cooling channel; 122, outlet; 123, inlet; 2, piezoelectric element; 21, piezoelectric array element; 22, positive electrode lead; 23, ground electrode lead; 24, protective layer. DETAILED DESCRIPTION

[0034] In order to make the above-mentioned purposes, features and advantages of the present application more obvious and easy to understand, the specific implementation methods of the present application are described in detail below in conjunction with the accompanying drawings. In the following description, many specific details are set forth to facilitate a full understanding of the present application. However, the present application can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present application, so the present application is not limited by the specific embodiments disclosed below.

[0035] Please refer to FIG1 . In the first aspect, the embodiment of the present application provides an ultrasonic head structure 100 , which includes an ultrasonic head body 1 and at least one piezoelectric element 2 . Please refer to FIG2 . The ultrasonic head body 1 is provided with a first accommodating cavity 111 and a second accommodating cavity 121 . The ultrasonic head body 1 is also provided with an ultrasonic port 112 communicating with the first accommodating cavity 111 , and an outlet 122 and an inlet 123 communicating with the second accommodating cavity 121 . The first accommodating cavity 111 is used to accommodate a coupling fluid, and the second accommodating cavity 121 is used to accommodate a cooling fluid. The piezoelectric element 2 is connected to the ultrasonic head body 1 and is located in the first accommodating cavity 111 . The piezoelectric element 2 is arranged at intervals from the ultrasonic port 112 , and the sound radiation surface of the piezoelectric element 2 faces the ultrasonic port 112 . The first accommodating cavity 111 is only used to accommodate the coupling fluid and to arrange the piezoelectric element 2 , which effectively reduces the contents in the first accommodating cavity 111 , so that the ultrasonic head structure 100 can better fit the human skin, can better adapt to the skin curve, provide better skin fit, and thus can increase the adsorption force between the ultrasonic head structure 100 and the human skin. At the same time, since the first accommodating chamber 111 is only provided with coupling fluid and piezoelectric element 2, the diffusion resistance of the drug inside the chamber can be reduced, the ultrasonic energy can be evenly distributed, the energy loss caused by skin displacement can be reduced, and the drug penetration efficiency can be improved. After the first accommodating chamber 111 of the ultrasonic head structure 100 accommodates the coupling fluid, the ultrasonic port 112 covers the human skin, so that the ultrasonic head structure 100 is adsorbed on the human skin to prevent the coupling fluid from overflowing from the edge of the ultrasonic port 112. The piezoelectric element 2 and the ultrasonic port 112 are arranged at intervals, so that a gap is formed between the piezoelectric element 2 and the skin surface, and the sound radiation surface of the piezoelectric element 2 faces the ultrasonic port 112, so that the coupling fluid in the first accommodating chamber 111 can induce the coupling fluid to produce inertial cavitation, convective mixing and micro-jet formation on the skin surface, which can facilitate breaking through the obstacles of the stratum corneum of the human skin and improve the drug penetration efficiency. By introducing the cooling fluid from the inlet 123 into the second accommodating chamber 121 and then passing it out through the outlet 122, the cooling fluid flows in the second accommodating chamber 121. The cooling fluid has a larger heat capacity and can effectively take away the heat generated by the piezoelectric element 2 when it is working to prevent overheating. Since the second accommodating chamber 121 is spaced apart from the first accommodating chamber 111, the pressure change caused by the cooling fluid flowing in the second accommodating chamber 121 will not directly affect the first accommodating chamber 111, and the pressure in the first accommodating chamber 111 can be kept stable, the transmission of pressure waves can be reduced, and the risk of coupling liquid leakage in the first accommodating chamber 111 can be reduced. Therefore, the embodiment of the present application can not only improve the adsorption force between the ultrasonic head structure 100 and the skin, but also improve the drug penetration efficiency, and can also facilitate heat dissipation by setting the first accommodating chamber 111 and the second accommodating chamber 121.

[0036] In the related art, in order to solve the heat dissipation problem of the piezoelectric element 2 of the ultrasonic probe, gas is directly introduced into the space where the piezoelectric element 2 is located to dissipate heat, but this design is not suitable for ultrasonic penetration between the coupling fluid and the human skin. On the one hand, in this structure, when the coupling fluid is used for cooling, the liquid cannot provide reduced pressure, which will interfere with the contact between the ultrasonic probe and the human skin, resulting in the inability of the ultrasonic probe to fit the human skin and causing the coupling fluid to overflow. On the other hand, the coupling fluid flows in the space where the piezoelectric element 2 is located to dissipate heat, which will result in poor cavitation effect of the coupling fluid on the skin surface, making it difficult to form convective mixing and microjets, affecting the drug penetration efficiency.

[0037] It should be noted that the cooling fluid in the embodiment of the present application is a liquid that can absorb heat and flow, such as an oil-based coolant or glycerol, etc. The cooling fluid can also be a liquid medicine. The coupling fluid refers to a liquid medicine in which therapeutic substances such as drugs are dissolved. In some embodiments, the cooling fluid and the coupling fluid are both liquid medicine. The ultrasonic head body 1 in the embodiment of the present application is all made of a flexible material that is close to the acoustic impedance of the coupling fluid and has good biocompatibility. For example, a copolymer or block copolymer of polyolefin, diene polymer, polysiloxane or a mixture thereof can be used. For example, polybutadiene, polydimethylsiloxane and polyether block amide. Preferably, the present application uses polydimethylsiloxane to make the ultrasonic head body 1. Polydimethylsiloxane has excellent fluidity, which is convenient for pouring liquid polydimethylsiloxane in the volume space of the mold. After curing, polydimethylsiloxane is colorless and transparent, and has very good flexibility. After curing, the acoustic impedance of substances such as water and liquid medicine is very close and has good biocompatibility.

[0038] In some embodiments, the first accommodating chamber 111 is not connected to the second accommodating chamber 121. In this case, the coupling fluid in the first accommodating chamber 111 and the cooling fluid in the second accommodating chamber 121 are isolated from each other. In this case, the cooling fluid and the coupling fluid may be the same or different, for example, the cooling fluid may use an oil-based coolant, and the coupling fluid may use a liquid medicine; or both may use liquid medicine. The coupling fluid may be filled in the first accommodating chamber 111 in advance, and then the ultrasonic head structure 100 may be covered on the skin, and then the cooling fluid may be introduced into the second accommodating chamber 121, and finally the ultrasonic treatment may be performed.

[0039] In other embodiments, the first accommodating chamber 111 is connected to the second accommodating chamber 121, and the coupling fluid in the first accommodating chamber 111 and the cooling fluid in the second accommodating chamber 121 are mutually fused and exchanged. In this case, the cooling fluid and the coupling fluid are the same, both are liquid medicine. The ultrasonic head structure 100 can be directly covered on the human skin, and then the liquid medicine is introduced into the second accommodating chamber 121. After the liquid medicine flows into the first accommodating chamber 111, ultrasonic treatment is finally performed.

[0040] By connecting the first accommodating chamber 111 and the second accommodating chamber 121, the liquid medicine can circulate in the first accommodating chamber 111 and the second accommodating chamber 121, the liquid medicine used for cooling in the second accommodating chamber 121 can flow into the first accommodating chamber 111, and the liquid heated by the ultrasonic wave in the first accommodating chamber 111 can also flow into the second accommodating chamber 121, and the cooled liquid medicine returns to the first accommodating chamber 111 after cooling, thereby improving heat exchange through the circulation process, facilitating the removal of heat, and improving cooling efficiency. Furthermore, the liquid medicine in the second accommodating chamber 121 can enter the first accommodating chamber 111 for replenishment, ensuring the continuous supply of liquid medicine, and maintaining a stable liquid medicine concentration, avoiding changes in drug concentration caused by the liquid medicine being absorbed by human skin. In addition, through circulation, the liquid medicine can be evenly distributed on the skin surface, ensuring the uniform penetration of ultrasonic energy and drugs, and improving drug penetration efficiency. Furthermore, the connected first accommodating chamber 111 and the second accommodating chamber 121 can be easily operated. It is only necessary to introduce the medicine into the second accommodating chamber 121 without operating the first accommodating chamber 111, which can reduce the waste of the medicine.

[0041] Please refer to FIG. 6. In some embodiments, the second accommodating cavity 121 can be directly formed by machining inside the ultrasonic head body 1 itself. Alternatively, a structure with an accommodating cavity such as a metal tube or a ceramic tube is provided in the ultrasonic head body 1 to form the second accommodating cavity 121 on the ultrasonic head body 1. The former is preferred, because the shape, size and depth of the second accommodating cavity 121 can be flexibly set to meet different heat dissipation requirements. At the same time, since the second accommodating cavity 121 is directly opened inside the ultrasonic head body 1, the cavity wall material of the second accommodating cavity 121 is consistent with the material of the ultrasonic head body 1, which has better material compatibility. When the first accommodating cavity 111 and the second accommodating cavity 121 are connected, the material of the drug liquid circulating in the two cavities is the same, which can reduce the difference in ultrasonic impedance and facilitate ultrasonic wave propagation and drug delivery.

[0042] The present application does not limit the location of the first accommodating chamber 111 and the second accommodating chamber 121. The second accommodating chamber 121 can be spaced apart at any location on the periphery of the first accommodating chamber 111. For example, the second accommodating chamber 121 is located on the left or right side or the upper or lower side of the first accommodating chamber 111. Any location where the pressure of the cooling fluid flowing in the second accommodating chamber 121 does not affect the adsorption force between the first accommodating chamber 111 and human skin is within the protection scope of the embodiments of the present application.

[0043] Please refer to FIG. 2. In some embodiments, the ultrasonic head body 1 includes a first part 11 and a second part 12 stacked along a first direction. The first part 11 is provided with a first accommodating cavity 111 and an ultrasonic port 112 along the first direction and on a surface away from the second part 12. The piezoelectric element 2 is connected to the first part 11. The second part 12 is provided with a second accommodating cavity 121 along the first direction and on a surface adjacent to the first part 11. The second accommodating cavity 121 extends along the second direction to the peripheral side surface penetrating the second part 12 to form an outlet 122 and an inlet 123. The first direction intersects with the second direction. Thus, the flow direction of the cooling fluid in the second accommodating cavity 121 is along the second direction, and the piezoelectric element 2 ultrasonically penetrates the human skin along the first direction. The cooling fluid flows along the second direction, which can effectively transfer the heat of the piezoelectric array element 21 from the center to the edge, reduce heat concentration, and be more conducive to heat dissipation. Furthermore, by arranging the second part 12 on the surface of the first part 11 away from the ultrasonic port 112 along the first direction, the available ultrasonic area of ​​the ultrasonic head structure 100 along the second direction can be increased, and as many ultrasonic ports 112 as possible can be arranged in the first part 11 along the second direction, thereby increasing the ultrasonic action area of ​​the piezoelectric array element 21, which is suitable for systemic treatment rather than being limited to local treatment.

[0044] Please refer to FIG. 2 and FIG. 5 , and first introduce the structure of the first part 11: in some embodiments, the first part 11 includes a base 114 and a plurality of enclosures 115, and the piezoelectric element 2 includes a plurality of them. Along the first direction, the surface of the base 114 is connected to the second part 12, and all the enclosures 115 are convexly arranged on the surface of the base 114 away from the second part 12. All the enclosures 115 and the base 114 are jointly constructed to form a first accommodating cavity 111, and each enclosure 115 is provided with an ultrasonic port 112, and each piezoelectric element 2 is located in an enclosure 115. The provision of the base 114 can isolate the first accommodating cavity 111 and the second accommodating cavity 121 from each other, and can reduce the influence of the cooling fluid flowing in the second accommodating cavity 121 on the adsorption force of the first accommodating cavity 111 on the skin. Compared to setting all the multiple piezoelectric elements 2 in one enclosure 115, the embodiment of the present application makes each piezoelectric element 2 correspond to one enclosure 115. When the multiple enclosures 115 are in contact with human skin, the contact area between the ultrasonic head structure 100 and the human skin can be increased, thereby improving the adsorption force between the first part 11 and the human skin. Each enclosure 115 forms an independent ultrasonic cavity with the piezoelectric element 2 inside it, which can improve the formation effect of coupling fluid cavitation, convective mixing and microjet, and can further improve the drug penetration efficiency. In addition, a piezoelectric element 2 is set in each enclosure 115, and the frequency of each piezoelectric element 2 can be independently controlled, thereby changing the ultrasonic effect of each piezoelectric element 2, which can facilitate the control of liquid medicine penetration.

[0045] Please refer to FIG. 5 . In some embodiments, a plurality of enclosures 115 may be arranged in an array on the substrate 114, so that the piezoelectric elements 2 are arranged in an array on the substrate 114. For example, there may be four enclosures 115, and the four enclosures 115 may be arranged centrally symmetrically about the center of the substrate 114. Correspondingly, there are also four piezoelectric elements 2. In addition, the number of enclosures 115 and piezoelectric elements 2 may also be 2, 3, 5, 6, 7, 8, etc., which can be changed according to the change of the area of ​​the treatment part of the human body, and a flexible array that is adaptive to the curved surface morphology of the skin can be realized.

[0046] Please refer to Fig. 5. In some embodiments, the first part 11 is provided with a leakage hole 113 on the surface adjacent to the second part 12 along the first direction, and the leakage hole 113 is connected to the first accommodating cavity 111 and the second accommodating cavity 121. The provision of the leakage hole 113 enables the liquid medicine in the second accommodating cavity 121 to penetrate into the first accommodating cavity 111. Compared with the provision of a through leakage groove, the connection area can be reduced, thereby reducing the influence of the pressure change generated by the liquid medicine flowing in the second accommodating cavity 121 on the pressure in the first accommodating cavity 111, thereby avoiding affecting the fit between the first part 11 and the human skin.

[0047] Please refer to Figures 3 and 5. In some embodiments, the first substrate 114 is provided with a plurality of leakage holes 113, each of which is provided in an enclosure 115 and connects the outer peripheral surface of the piezoelectric element 2 and the inner peripheral surface of the enclosure 115. Thus, the liquid medicine in the second accommodation cavity 121 can flow into the first accommodation cavity 111 formed by the plurality of enclosures 115 through the plurality of leakage holes 113, and the size of the leakage hole 113 can be easily controlled to minimize the opening area of ​​the leakage hole 113, thereby further reducing the influence of the setting of the leakage hole 113 on the adsorption force of the first part 11.

[0048] In some embodiments, the enclosure 115 may be a cylindrical ring body, or may be a trumpet-shaped ring body. The trumpet-shaped ring body can improve the adsorption force of the enclosure 115 on the human body.

[0049] Please refer to Figures 3 and 7, and then introduce the structure of the piezoelectric element 2: In some embodiments, the piezoelectric element 2 may be in a circular, square or polygonal shape. The enclosure 115 may be in a circular, square or polygonal shape. The piezoelectric element 2 may be located in the center of the enclosure 115 or in a non-central setting. Preferably, in some embodiments, the enclosure 115 is a ring body, the piezoelectric element 2 is a cylinder, and each piezoelectric element 2 is concentrically arranged with each enclosure 115. Thus, the edges of the enclosure 115 and the piezoelectric element 2 are continuously arranged, which can reduce the edge effect during energy transfer, improve the uniformity of energy transfer, and further improve the drug penetration effect. In addition, the enclosure 115 is a ring body, and when the enclosure 115 contacts the human skin, it can reduce the formation of air bubbles and reduce the blind area of ​​energy transfer.

[0050] Please refer to FIG3 , in some embodiments, the diameter d1 of the piezoelectric element 2 is 8 mm to 12 mm; please refer to FIG4 , the thickness d2 of the piezoelectric element 2 is 0.5 mm to 3 mm. As a result, the piezoelectric element 2 can have a resonant frequency with a high response intensity: the resonant frequency along the radial direction of the piezoelectric element 2 is about 200 KHz, which can make the piezoelectric element 2 in the radial vibration mode in the diameter direction when working, which can not only produce better cavitation microbubbles, but also form better microjets and promote bubble rupture, reduce the suspension of cavitation microbubbles in the coupling fluid, and improve the shaking effect of cavitation microbubbles. In addition, the resonant frequency of 200KHz belongs to medium-frequency ultrasound. Using medium-frequency ultrasound to induce acoustic cavitation can produce larger volumes of cavitation microbubbles, stronger shock waves, more cavitation microbubble ruptures and more microjets. At the same time, it can reduce the volume and mass of the piezoelectric array element 21. When the diameter of the piezoelectric element 2 remains unchanged, the thickness of the piezoelectric element 2 can be reduced, the volume of the first accommodating cavity 111 can be reduced, and the discomfort of fitting with human skin can be reduced.

[0051] It should be noted that the use of low-frequency ultrasound (20KHz~100KHz) to induce acoustic cavitation requires the use of a piezoelectric element 2 with a larger volume and mass, which will increase the user's discomfort. The use of high-frequency ultrasound (over 1MHz) to induce acoustic cavitation forms a thickness vibration mode. From the sound pressure contour map, it can be seen that if the thickness vibration mode is used, the energy of the sound field will be concentrated on the central axis, and the sound field will be relatively uneven in space, making it difficult to form microjets or bubble ruptures. The state of the cavitation microbubbles generated is similar to hovering, shaking in a smaller spatial range, which is not conducive to the penetration of drugs.

[0052] Exemplarily, the diameter d1 of the piezoelectric element 2 can be any value within the above range, for example, 8 mm, 9 mm, 10 mm, 11 mm, 12 mm, etc. The thickness d2 of the piezoelectric element 2 can be any value within the above range, for example, 0.5 mm, 0.8 mm, 1.0 mm, 1.2 mm, 1.4 mm, 1.6 mm, 1.8 mm, 2.0 mm, 2.2 mm, 2.4 mm, 2.6 mm, 2.8 mm, 3.0 mm, etc.

[0053] Please refer to FIG. 3 . In some embodiments, the center distance d3 of two adjacent piezoelectric elements 2 is 15 mm to 25 mm. This can reduce the mutual interference between the piezoelectric elements 2, improve the drug penetration efficiency, avoid local overheating, and ensure the drug administration area. Exemplarily, d3 can be any point value within the above range, such as 15 mm, 16 mm, 17 mm, 18 mm, 19 mm, 20 mm, 21 mm, 22 mm, 23 mm, 24 mm, 25 mm, etc.

[0054] Please refer to FIG. 3 . In some embodiments, the distance between the outer circumference of the piezoelectric element 2 and the inner circumference of the enclosure 115 is d4, which satisfies: 0.5 mm ≤ d4 ≤ 1.5 mm. This can avoid blocking the sound field on the sides of the piezoelectric element 2, and form a first accommodating cavity 111 for storing the coupling fluid between the piezoelectric element 2 and the enclosure 115. Exemplarily, d4 can be any point value within the above range, such as 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1.0 mm, 1.1 mm, 1.2 mm, 1.3 mm, 1.4 mm, 1.5 mm, etc.

[0055] Please refer to FIG. 3 . In some embodiments, the spacing between the inner circumference of the enclosure 115 and its outer circumference is d5, which satisfies: 1.5 mm ≤ d5 ≤ 2.5 mm. In other words, the wall thickness of the enclosure 115 is d5. This can avoid affecting the propagation efficiency of ultrasonic waves in the enclosure 115, reduce interference with ultrasonic wave transmission, and reduce vibration damping of the piezoelectric array element 21. Exemplarily, d5 can be any point value within the above range, such as 1.5 mm, 1.6 mm, 1.7 mm, 1.8 mm, 1.9 mm, 2.0 mm, 2.1 mm, 2.2 mm, 2.3 mm, 2.4 mm, 2.5 mm, etc.

[0056] Please refer to FIG. 4 . In some embodiments, along the first direction and away from the first substrate 114, the spacing d6 between the bottom surface of the piezoelectric element 2 and the bottom surface of the enclosure 115 is 0.5 mm to 1.5 mm. Thus, a first accommodating cavity 111 for accommodating another part of the coupling fluid is formed between the bottom surface of the piezoelectric element 2 and the bottom surface of the enclosure 115. Controlling the spacing within this range can control the relative spacing between the piezoelectric element 2 and the surface of the human skin, so that the space generated between the piezoelectric element 2 and the human skin can provide a storage space for the coupling fluid medium, which is convenient for inducing the coupling fluid to generate inertial cavitation, convective mixing and microjet formation on the skin surface, making it easier to break through the barrier of the stratum corneum and increase the drug penetration efficiency. At the same time, the space can also increase the adsorption force between the transducer and the skin. Exemplarily, d6 can be any value within the above range, for example, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1.0 mm, 1.1 mm, 1.2 mm, 1.3 mm, 1.4 mm, 1.5 mm, etc.

[0057] Please refer to FIG. 7 . In some embodiments, each piezoelectric element 2 includes a piezoelectric array element 21, a positive electrode lead 22 and a ground electrode lead 23. The positive electrode lead 22 and the ground electrode lead 23 are arranged in the same plane. The piezoelectric array element 21 is connected to the bottom surface of the substrate 114. The positive electrode lead 22 and the ground electrode lead 23 are electrically connected to the piezoelectric array element and are embedded in the substrate 114. The positive electrode lead 22 and the ground electrode lead 23 are arranged in the same plane as much as possible, so that the positive electrode lead 22 and the ground electrode lead 23 can be arranged on different sides to avoid affecting the bending property of the ultrasonic head structure 100, thereby improving the flexibility of the ultrasonic head structure 100, and better adapting to the curve of human skin for easy attachment.

[0058] Since the substrate 114 is a flexible material, it can cover the positive electrode lead 22 and the ground electrode lead 23, so that when the ultrasonic head structure 100 is bent, the bending of the positive electrode lead 22 and the ground electrode lead 23 can be buffered. In order to increase the connection strength between the positive electrode lead 22 and the ground electrode lead 23 and the substrate 114, an adhesion promoter can be coated on the positive electrode lead 22 and the ground electrode lead 23.

[0059] In other embodiments, the positive electrode lead 22 and the ground electrode lead 23 may be connected in a non-coplanar manner. For example, the positive electrode lead 22 and the ground electrode lead 23 are disposed on two opposite sides of the piezoelectric array element 21 .

[0060] Please refer to FIG7 . Furthermore, the positive electrode leads 22 of all the piezoelectric elements 2 are connected to one end, and the ground electrode leads 23 of all the piezoelectric elements 2 are also connected to one end, so that all the piezoelectric elements 2 can be excited simultaneously. When it is necessary to excite each piezoelectric array element 21 individually, the positive electrode lead 22 of each piezoelectric element 2 can also be led out individually without being connected together, and the ground electrode lead 23 can also be led out individually without being connected together.

[0061] Optionally, the positive lead 22 and the ground electrode lead 23 may be straight or curved. The curved positive lead 22 and the ground electrode lead 23 have better deformation ability, thereby improving the flexibility of the ultrasound head structure 100 to better adapt to the curve of human skin and maintain better fit.

[0062] It should be noted that since the vibration direction of the piezoelectric element 2 in the embodiment of the present application is the diameter direction, the operating frequency of the piezoelectric element 2 is the radial resonance frequency, and the direction of the applied electric field of the piezoelectric element 2 is perpendicular to its vibration direction, in order to increase the radiation area and uniformity of the sound field, the surface where the ground electrode lead 23 is located is used as the radiation surface. Therefore, the sound radiation surface of the piezoelectric element 2 in the embodiment of the present application faces the ultrasonic port 112.

[0063] Referring to FIG. 2 and FIG. 8 , in some embodiments, the peripheral surface and bottom surface of the piezoelectric element 2 facing the ultrasonic port 112 are covered with a protective layer 24, and the material of the protective layer 24 and the material of the ultrasonic head body 1 are both flexible materials. The protective layer 24 can cover the piezoelectric element 2 without increasing the vibration damping of the array element. In order to increase the connection strength between the piezoelectric element 2 and the protective layer 24, the piezoelectric element 2 can be pre-treated, and an adhesion promoter can be applied to the peripheral surface and bottom surface of the piezoelectric element 2.

[0064] Optionally, the piezoelectric array element 21 may be a piezoelectric ceramic wafer, a piezoelectric single crystal, a piezoelectric film, a capacitive or piezoelectric micromechanical ultrasonic vibrator, etc. Optionally, the positive electrode lead 22 and the ground electrode lead 23 may be manufactured by magnetron sputtering, chemical plating, 3D printing of liquid metal leads, etc.

[0065] Please refer to FIG. 6 , and then the structure of the second part 12 is introduced: in some embodiments, the second accommodating cavity 121 includes a plurality of cooling grooves 1211 and a plurality of cooling channels 1212. Along the second direction, the cooling channels 1212 are located around the cooling grooves 1211, and two adjacent cooling grooves 1211 are connected through the cooling channels 1212. The outline size of the cooling grooves 1211 is greater than or equal to the outline size of the piezoelectric element 2. Along the first direction, the outline edge of the cooling groove 1211 coincides with the outline edge of the piezoelectric element 2 or is located at the periphery of the outline edge of the piezoelectric element 2. As a result, the cooling grooves 1211 can completely cover the piezoelectric element 2, which can increase the cooling area of ​​the cooling fluid, and thus can improve the heat dissipation effect of the cooling fluid.

[0066] Please refer to FIG. 5 and FIG. 6. In some embodiments, the leakage hole 113 is connected to the first accommodating chamber 111 and the cooling groove 1211 at the same time. Compared with the leakage hole 113 being connected to the cooling channel 1212, the leakage hole 113 is arranged in the cooling groove 1211 corresponding to the piezoelectric element 2, which can reduce the influence of the liquid flow pressure in the first accommodating chamber 111 on the ultrasonic liquid in the first accommodating chamber 111, and reduce the influence on the first part 11 adsorbing human skin. In addition, by pressing the second part 12 at the position of the cooling groove 1211, the adsorption force between the first accommodating chamber 111 and the skin can be made stronger.

[0067] In the second aspect, the embodiment of the present application further provides an ultrasonic device, which includes the ultrasonic head structure 100 as in the first aspect, and the ultrasonic device also includes a pumping device, the input end of the pumping device is connected to the inlet 123 of the ultrasonic head body 1, and the output end is connected to the outlet 122 of the ultrasonic head, and the pumping device is used to pump the cooling fluid from the inlet 123 into the second accommodating cavity 121, and pump out the outlet 122 from the second accommodating cavity 121. Exemplarily, the pumping device is a liquid medicine pump. The ultrasonic device provided in the embodiment of the present application also has all the technical effects of the ultrasonic head structure 100, which will not be repeated here.

[0068] In summary, the embodiment of the present application provides an ultrasonic head structure 100, which is flexible as a whole, can adapt to the curved surface of human skin, and can ensure good adhesion to human skin. At the same time, the ultrasonic head structure 100 can be in a radial vibration mode, can produce better cavitation microbubbles, form more microjets and rupture bubbles, and improve the penetration efficiency of drugs. The piezoelectric element 2 of the present application is smaller in size and lighter in weight, and is suitable for portable use. At the same time, heat dissipation and cooling can be achieved, so that the liquid medicine can be continuously circulated and supplied in the ultrasonic head structure 100.

[0069] In the description of the present application, it should be understood that if the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", "clockwise", "counterclockwise", "axial", "radial", "circumferential", etc. appear, the orientation or position relationship indicated by these terms is based on the orientation or position relationship shown in the accompanying drawings, which is only for the convenience of describing the present application and simplifying the description, and does not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on the present application.

[0070] In addition, if the terms "first" or "second" appear, these terms are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Therefore, a feature defined as "first" or "second" may explicitly or implicitly include at least one of the features. In the description of this application, if the term "plurality" appears, the meaning of "plurality" is at least two, such as two, three, etc., unless otherwise clearly and specifically defined.

[0071] In this application, unless otherwise clearly specified and limited, if the terms "installed", "connected", "connected", "fixed" and the like appear, these terms should be understood in a broad sense. For example, it can be a fixed connection, a detachable connection, or an integrated connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium, it can be the internal connection of two elements or the interaction relationship between two elements, unless otherwise clearly defined. For ordinary technicians in this field, the specific meanings of the above terms in this application can be understood according to the specific circumstances.

[0072] In the present application, unless otherwise clearly specified and limited, if there is a description that a first feature is "above" or "below" a second feature, etc., or similar descriptions appear, it may mean that the first and second features are in direct contact, or that the first and second features are in indirect contact through an intermediate medium. Moreover, the first feature being "above", "above" and "above" the second feature may mean that the first feature is directly above or obliquely above the second feature, or simply means that the first feature is higher in level than the second feature. The first feature being "below", "below" and "below" the second feature may mean that the first feature is directly below or obliquely below the second feature, or simply means that the first feature is lower in level than the second feature.

[0073] It should be noted that if an element is referred to as being "fixed to" or "disposed on" another element, it may be directly on the other element or there may be a central element. If an element is considered to be "connected to" another element, it may be directly connected to the other element or there may be a central element at the same time. If any, the terms "vertical", "horizontal", "upper", "lower", "left", "right" and similar expressions used in this application are for illustrative purposes only and do not represent the only implementation method.

[0074] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0075] The above-described embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be construed as limiting the scope of the patent application. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent application shall be subject to the attached claims.

Claims

1. An ultrasonic head structure, characterized in that: include: An ultrasonic head body, wherein a first accommodating cavity and a second accommodating cavity are provided in the ultrasonic head body, and the ultrasonic head body is further provided with an ultrasonic port communicated with the first accommodating cavity and an outlet and an inlet communicated with the second accommodating cavity, the first accommodating cavity is used to accommodate a coupling fluid, and the second accommodating cavity is used to accommodate a cooling fluid; as well as At least one piezoelectric element is connected to the ultrasonic head body and is located in the first accommodating cavity. The piezoelectric element is spaced apart from the ultrasonic port, and the sound radiation surface of the piezoelectric element faces the ultrasonic port.

2. The ultrasonic head structure according to claim 1, characterized in that: The ultrasonic head body includes a first part and a second part stacked along a first direction, the first part is provided with the first accommodating cavity and the ultrasonic port along the first direction and on a surface facing away from the second part, the piezoelectric element is connected to the first part, the second part is provided with the second accommodating cavity along the first direction and on a surface adjacent to the first part, the second accommodating cavity extends along the second direction to the peripheral side surface penetrating the second part to form the outlet and the inlet, and the first direction intersects with the second direction.

3. The ultrasonic head structure according to claim 2, characterized in that: A liquid leakage hole is provided on a surface of the first part along the first direction and adjacent to the second part, and the liquid leakage hole is communicated with the first accommodating cavity and the second accommodating cavity at the same time.

4. The ultrasonic head structure according to claim 2, characterized in that: The first part includes a base and a plurality of enclosures, and the piezoelectric elements include a plurality of them. In the first direction, the surface of the base is connected to the second part, and all the enclosures are protruded from the surface of the base facing away from the second part. All the enclosures and the base are jointly constructed to form the first accommodating cavity, and each of the enclosures is provided with an ultrasonic port, and each of the piezoelectric elements is located in one of the enclosures.

5. The ultrasonic head structure according to claim 4, characterized in that: The enclosure is a ring, the piezoelectric element is a cylinder, and each of the piezoelectric elements is concentrically arranged with each of the enclosures; And / or, the diameter d1 of the piezoelectric element is 8 mm to 12 mm; And / or, the thickness d2 of the piezoelectric element is 0.5 mm to 3 mm; And / or, the center distance d3 between two adjacent piezoelectric elements is 15 mm to 25 mm; And / or, the distance d4 between the outer circumference of the piezoelectric element and the inner circumference of the enclosure is 0.5 mm to 1.5 mm; And / or, the distance d5 between the inner circumference and the outer circumference of the enclosure is 1.5 mm to 2.5 mm; And / or, along the first direction and in a direction away from the substrate, a distance d6 between a bottom surface of the piezoelectric element and a bottom surface of the enclosure is 0.5 mm to 1.5 mm.

6. The ultrasonic head structure according to claim 4, characterized in that: Each of the piezoelectric elements includes a piezoelectric array element, a positive electrode lead and a ground electrode lead. The positive electrode lead and the ground electrode lead are arranged coplanarly, the piezoelectric array element is connected to the bottom surface of the substrate, and the parts of the positive electrode lead and the ground electrode lead electrically connected to the piezoelectric array element are embedded in the substrate.

7. The ultrasonic head structure according to claim 2, characterized in that: The second accommodating cavity includes a plurality of cooling grooves and a plurality of cooling channels. In the second direction, the cooling channels are located on the periphery of the cooling grooves, and two adjacent cooling grooves are connected by the cooling channels. The contour size of the cooling grooves is greater than or equal to the contour size of the piezoelectric element. In the first direction, the contour edge of the cooling groove coincides with the contour edge of the piezoelectric element or is located on the periphery of the contour edge of the piezoelectric element.

8. The ultrasonic head structure according to claim 7, characterized in that: A liquid leakage hole is provided on a surface of the first part along the first direction and adjacent to the second part, and the liquid leakage hole is communicated with the first accommodating cavity and the cooling groove respectively.

9. The ultrasonic head structure according to any one of claims 1 to 8, characterized in that: The peripheral surface and bottom surface of the piezoelectric element facing the ultrasonic port are covered with a protective layer, and the material of the protective layer and the material of the ultrasonic head body are both flexible materials.

10. An ultrasonic device, characterized in that: The ultrasonic device comprises the ultrasonic head structure according to any one of claims 1 to 9.